BioSpace· Annalee Armstrong·· 2 days agoScore87
ESMO 2026: Analysts warm to Merck, Moderna’s cancer vaccine after frustrating data leak
In brief
After the INTerpath-001 data leaked prematurely, several analysts consider the 42% reduction in the risk of melanoma recurrence or death achieved by intismeran autogene combined with Keytruda acceptable.
Source: BioSpace · biospace.com